- Report
- June 2024
- 41 Pages
Global
From €2201EUR$2,499USD£1,935GBP
- Report
- November 2022
- 230 Pages
Global
From €2477EUR$2,813USD£2,177GBP
€3303EUR$3,750USD£2,903GBP
- Report
- February 2022
- 249 Pages
Global
From €2477EUR$2,813USD£2,177GBP
€3303EUR$3,750USD£2,903GBP
- Report
- September 2022
- 220 Pages
Global
From €2114EUR$2,400USD£1,858GBP
- Report
- May 2025
- 100 Pages
China
From €5240EUR$5,950USD£4,606GBP
- Report
- April 2023
- 116 Pages
Global
From €3963EUR$4,500USD£3,484GBP
- Report
- December 2022
- 120 Pages
Global
From €3963EUR$4,500USD£3,484GBP
- Report
- November 2022
- 119 Pages
Global
From €3963EUR$4,500USD£3,484GBP
- Report
- August 2023
- 250 Pages
Global
From €1753EUR$1,990USD£1,541GBP
- Report
- July 2022
- 40 Pages
China
From €2818EUR$3,200USD£2,477GBP
- Report
- May 2021
- 50 Pages
China
From €2290EUR$2,600USD£2,013GBP
- Report
- April 2021
- 40 Pages
China
From €2290EUR$2,600USD£2,013GBP
- Report
- March 2022
- 300 Pages
Global
From €4404EUR$5,000USD£3,871GBP
- Report
- July 2024
- 100 Pages
Global
From €2642EUR$3,000USD£2,323GBP
€3303EUR$3,750USD£2,903GBP
- Report
- June 2024
- 200 Pages
Global
From €5602EUR$6,360USD£4,924GBP
€7002EUR$7,950USD£6,155GBP
- Report
- June 2024
- 200 Pages
Global
From €5602EUR$6,360USD£4,924GBP
€7002EUR$7,950USD£6,155GBP
- Report
- June 2024
- 200 Pages
Global
From €5602EUR$6,360USD£4,924GBP
€7002EUR$7,950USD£6,155GBP
- Report
- June 2024
- 200 Pages
Global
From €5602EUR$6,360USD£4,924GBP
€7002EUR$7,950USD£6,155GBP
- Report
- June 2024
- 200 Pages
Global
From €5602EUR$6,360USD£4,924GBP
€7002EUR$7,950USD£6,155GBP
- Report
- June 2024
- 200 Pages
Global
From €5602EUR$6,360USD£4,924GBP
€7002EUR$7,950USD£6,155GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more